Contact
Please use this form to send email to PR contact of this press release:
Capricor Therapeutics Announces DSMB Recommendation to Continue Phase II INSPIRE Trial for Severe COVID-19 Patients
TO:
Please use this form to send email to PR contact of this press release:
Capricor Therapeutics Announces DSMB Recommendation to Continue Phase II INSPIRE Trial for Severe COVID-19 Patients
TO: